Synektik

Synektik Debt / Assets

The Debt-to-Assets Ratio of Synektik (SNT.WA) as of Oct 31, 2026 is 0.08. In the previous year, Debt-to-Assets Ratio was 0.07 — a change of 26.67% (higher).

Debt / Assets

0.08

YoY

26.67%

Last updated:

Debt-to-Assets Ratio of Synektik is 2025 0.08 . Debt-to-Assets Ratio of Synektik was 2024 0.07 . It decreases by 26.67% higher compared to the previous year.

The Synektik Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2018
0.15 PLN
Jan 1, 2019
0.10 PLN
Jan 1, 2020
0.15 PLN
Jan 1, 2021
0.11 PLN
Jan 1, 2022
0.16 PLN
Jan 1, 2023
0.06 PLN
Jan 1, 2024
0.07 PLN
Jan 1, 2025
0.08 PLN
The Synektik Debt / Assets history
YEARDebt / AssetsYoY
0.08+26.67%
0.07+4.55%
0.06-59.98%
0.16+37.08%
0.11-21.70%
0.15+49.34%
0.10-34.66%
0.15+424.06%
0.03-54.89%
0.06-22.58%
0.08-29.58%
0.12—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Debt-to-Assets Ratio of Synektik is 0.08 in 2025.

Debt-to-Assets Ratio of Synektik changed from 0.07 to 0.08, representing a 26.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio Synektik since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's Synektik with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Synektik

All Key Metrics — Synektik